Sionna Therapeutics, Inc.
SION
$6.46
-$0.08-1.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 37.45M | 33.36M | 28.72M | 24.16M | 19.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 109.49M | 98.92M | 88.98M | 83.50M | 87.68M |
| Operating Income | -109.49M | -98.92M | -88.98M | -83.50M | -87.68M |
| Income Before Tax | -97.38M | -85.57M | -75.27M | -70.68M | -75.84M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -97.38 | -85.57 | -75.27 | -70.68 | -75.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -97.38M | -85.57M | -75.27M | -70.68M | -75.84M |
| EBIT | -109.49M | -98.92M | -88.98M | -83.50M | -87.68M |
| EBITDA | -108.84M | -98.28M | -88.34M | -82.84M | -87.04M |
| EPS Basic | -2.17 | -1.92 | -1.95 | -4.87 | -10.08 |
| Normalized Basic EPS | -1.36 | -1.20 | -1.22 | -3.04 | -6.30 |
| EPS Diluted | -2.17 | -1.92 | -1.95 | -4.87 | -10.08 |
| Normalized Diluted EPS | -1.36 | -1.20 | -1.22 | -3.04 | -6.30 |
| Average Basic Shares Outstanding | 178.96M | 177.93M | 159.60M | 119.66M | 79.89M |
| Average Diluted Shares Outstanding | 178.96M | 177.93M | 159.60M | 119.66M | 79.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |